Childhood Tuberculosis Meeting 2011Archived
ECDC is hosting a meeting on childhood TB, in a joint effort to highlight the current situation and to move forward the agenda of childhood TB in the EU and worldwide.
The meeting intends to:
- Identify and highlight the gaps, challenges and needs in childhood TB control.
- Prepare the scientific rationale for the need of advocacy and to identify the key areas where more advocacy and targeted engagement with stakeholders is needed.
- Reach a consensus on how to advocate for childhood TB control in light of the MDG 4 for child survival and how to bring forward the voice of the children.
Place of event: Piperska Muren Conference, Scheelegatan 14, Stockholm, Sweden
Registration for attending the meeting is closed. Agenda:
|
Thursday - 17 March 2011 |
|
| Setting the scene of day one |
08:55: Chair for day one: Robert Gie 09:00:Welcome – Johan Giesecke 09.05: Aims and objectives of the meeting – Davide Manissero/Malgorzata Grzemska 09:10: Historical overview of the STBP childhood subgroup – Robert Gie |
| Epidemiologic situation of TB in children |
09:25: Global childhood TB situation with a focus on high-burden countries – Babis Sismanidis 09:35: Childhood TB in low and medium-burden countries – Andreas Sandgren |
| Programmatic successes and failures in childhood TB control |
09:50: View of low-incidence high-resource countries – Ibrahim Abubakar 10.05: View of technical assistance to high-burden countries – Steve Graham 10:30: COFFEE BREAK |
|
Integration of childhood TB care in HIV, antenatal and community health programmes
|
11:00: How is community-based MDR TB treatment provided in Lesotho – Hind Satti 11:20: How could TB and HIV care for children and women be integrated – Lynne Mofenson 11:40: How could local childhood health workers/ community be involved –Tahmeed Ahmed 12:00: How could the private sector contribute in high-burden countries – Aamir Khan 12.15: Panel discussion lead by the discussant – Malgorzata Grzemska 12:45: LUNCH |
| Identify the needs in research and development for childhood TB |
14:00 What is done to develop vaccines effective in children – Anthony Hawkridge 14:25 What is lacking in the development of new diagnostics – Luis Cuevas14.50 What is done to develop new drugs and involve children in clinical trials – Anneke Hesseling 15:20: COFFEE BREAK 16:00 How to ensure basic research and optimal use of new tools for TB control in children – Beate Kampmann 16:25 The place of childhood TB in the Global TB Research Roadmap – Christian Lienhardt 16.45 Panel discussion lead by the discussant – Soumya Swaminathan (Discussant to provide a 5 minutes ice breaker comment/view) 17:15 Conclusions of the first day - Robert Gie and Davide Manissero 18:00 DINNER |
| Friday - 18 March 2011 | |
| Setting the scene of day two |
08:55: Chair for day two - Johan Giesecke 09:00 Keynote address – on behalf of the Executive Secretary of Stop TB Partnership, Lucica Ditiu (Sahu Suvanand) 09:05: Recorded Keynote address – the WHO Regional Director for Europe, Zsuzsanna Jakab (Adobe Flash Player required) 09:10: Personal reflection by ECDC director – Marc Sprenger 09:25: Screening of Euronews documentary (Adobe Flash Player required) |
| Why we need advocacy for childhood TB |
09:40: Summary of day one – Malgorzata Grzemska 09:50: Situation, gaps and challenges in advocacy for childhood TB – Claire Wingfield 10:05: The role of advocacy in the fight against childhood TB – Davide Manissero Screening of ECDC documentary on childhood TB (Adobe Flash Player required) 10:15: Ethical considerations – Marc Guerrier 10:30: COFFEE BREAK |
| Which messages should we use to advocate for childhood TB |
11:00: What can we learn from health journalists committed to TB – Bharathi Ghanashyam 11:30: How could we build joined forces with MDG4 – Ben J Marais |
| Stating the case of funding for childhood TB, donors expectations |
11:50: Global Fund – Philippe Creach 12:00: Donor experience and perspective - USAID, Clydette Powell 12:10: A NIAID Perspective - DAIDS/NIAID/NIH, Betsy Smith 12:20: Panel discussion lead by the discussant – Steve Graham 12:45: LUNCH |
| Collecting the views from the floor |
13:45: Civil society 13:50: NTP manager 13:55: Paediatrician 14:00: Pharmaceutical industry 14:05: Ethicist 14:10: Patient’s view 14:15: Discussion lead by the discussant – Aamir Khan 15:00: COFFEE BREAK |
| Outcome of the meeting |
15:30: Presenting the draft of the call for action paper – Robert Gie 16:00: Discussion & Conclusion |